Alle Arbeitgeber
Celea Therapeutics
Details
About Celea Therapeutics
Celea Therapeutics is dedicated to advancing transformative treatments for people with serious respiratory diseases. The company’s lead program, deupirfenidone (LYT-100), is currently in Phase 3 clinical development, representing a potential new standard of care for idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases.
Career Opportunities
Celea Therapeutics offers a dynamic working environment that emphasizes professional growth and collaboration. The company values accountability, transparency, collaboration, innovation, and passion, creating a culture where employees can thrive.
- Opportunities for professional development and advancement
- A collaborative and innovative work culture
- Commitment to making a meaningful impact in healthcare
